| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_845fee95f67274a4c4eeddfe2754d02e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N33-02 |
| filingDate |
2010-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6b71a37c88a43297cbeb72071c58098 |
| publicationDate |
2011-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011041687-A1 |
| titleOfInvention |
Methods of treating sialorrhea with bupropion and its metabolites |
| abstract |
Methods of treating sialorrhea in a patient by administering bupropion, bupropion metabolites or pharmaceutically acceptable salts thereof are disclosed. In certain embodiments, a pharmaceutical composition comprising a therapeutically effective amount of bupropion, bupropion metabolite and a pharmaceutically acceptable salt is administered to a patient to treat sialorrhea. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3520803-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019149861-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102013009114-A1 |
| priorityDate |
2009-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |